ABOUT US

GET TO KNOW CND LIFE SCIENCES

Since our founding, CND Life Sciences has been on a mission to advance the care of patients who face the potential diagnosis of a neurodegenerative disease. With long careers in research and clinical care, our founders  set out to unlock  deeper stories within the skin by  detecting key pathological markers in the peripheral nervous system that had been previously out of reach.

FAST FACTS

  • Founded in 2017 as Cutaneous NeuroDiagnostics, LLC 
  • Headquartered in Phoenix, Awith a CLIA-certified lab 
  • Founders: Drs. Todd Levine, MD, Christopher Gibbons, MD, and Roy Freeman, MD 
  • Research agreements with multiple biopharmaceutical companies 
  • Launched the Syn-One Test™ in August 2019 
  • In-network contracts with Medicare and other payors 

Values

CND maintains core values that guide our work and mission every day.

  • Great science. It’s the foundation of everything we do.
  • Patients first. There is a patient hoping for answers behind every test we perform – we never forget that.
  • Clinician-minded. We are founded by physicians and dedicated to helping clinicians care for patients – we embrace this responsibility.
  • Quality core. We adhere to high laboratory standards and quality practices – it’s the only way to operate.
  • Always thinking. We are relentless in determining how we can innovate and do better – it’s just in our DNA.
  • Respect. We hold our employees, customers, partners, and suppliers in high regard – we succeed when we are aligned.

Vision

Using more convenient, minimally invasive techniques supported by strong evidence, we see the day when physicians can access objective pathological insights on underlying diseases processes – much earlier in disease progression – and apply those insights to generate better outcomes for patients.

Today we see opportunity literally beneath the surface of the skin. Tomorrow we will help physicians and patients detect and treat neurodegenerative diseases easier, safer, and more effective than ever before.

Team

Richard J. Morello

RICHARD J. MORELLO
Chief Executive Officer
Read bio

Todd Levine

TODD D. LEVINE, MD
Founder & Medical Director
Read bio

Karina Solis

KARINA SOLIS
Laboratory Director
Read bio

Bailey Bellaire

BAILEY BELLAIRE
Senior Biomedical Engineer
Read bio

Scientific Advisors

Chris Gibbons

CHRISTOPHER GIBBONS, MD, MMSc, FAAN, FAAS
Founder & Senior Scientific Advisor
Read bio

Roy Freeman

ROY FREEMAN, MD
Founder & Senior Scientific Advisor 
Read bio

RESEARCH PARTNERS

CND Life Sciences is committed to innovation and advancing the science of diagnostic testing in the field of neurodegenerative diseases. We have received support for investigator-initiated trials and formed important research collaborations with biopharmaceutical sponsors and other partners to explore how our unique technology can help drive new diagnostic pathways and support patient care.

Our current sponsors and partners:

Mitsubishi Tanabe Pharma America
Sparc logo
Alterity Therapeutics

For Clinicians: Request a Syn-One Test™ Kit

The Syn-One Test provides objective pathological evidence to aid in the diagnosis of a synucleinopathy. Simply collect three small punch skin biopsies from your patient, send them to our CLIA-certified lab, and CND Life Sciences will provide important visual insights to support a diagnosis. If you are a clinician, click below to order a Syn-One Test Biopsy Kit.

Order a Kit